Preparation of Nanobubbles Carrying Androgen Receptor siRNA and Their Inhibitory Effects on Androgen-Independent Prostate Cancer when Combined with Ultrasonic Irradiation
Authors:
Open Access
- 5 May 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e96586
Abstract
The objective of this study was to investigate nanobubbles carrying androgen receptor (AR) siRNA and their in vitro and in vivo anti-tumor effects, when combined with ultrasonic irradiation, on androgen-independent prostate cancer (AIPC). Nanobubbles carrying AR siRNA were prepared using poly-L-lysine and electrostatic adsorption methods. Using C4-2 cell activity as a testing index, the optimal irradiation parameters (including the nanobubble number/cell number ratio, mechanical index [MI], and irradiation time) were determined and used for transfection of three human prostate cancer cell lines (C4-2, LNCaP, and PC-3 cells). The AR expression levels were investigated with RT-PCR and Western blot analysis. Additionally, the effects of the nanobubbles and control microbubbles named SonoVue were assessed via imaging in a C4-2 xenograft model. Finally, the growth and AR expression of seven groups of tumor tissues were assessed using the C4-2 xenograft mouse model. The nanobubbles had an average diameter of 609.5±15.6 nm and could effectively bind to AR siRNA. Under the optimized conditions of a nanobubble number/cell number ratio of 100∶1, an MI of 1.2, and an irradiation time of 2 min, the highest transfection rates in C4-2, LNCaP, and PC-3 cells were 67.4%, 74.0%, and 63.96%, respectively. In the C4-2 and LNCaP cells, treatment with these binding nanobubbles plus ultrasonic irradiation significantly inhibited cell growth and resulted in the suppression of AR mRNA and protein expression. Additionally, contrast-enhanced ultrasound showed that the nanobubbles achieved stronger signals than the SonoVue control in the central hypovascular area of the tumors. Finally, the anti-tumor effect of these nanobubbles plus ultrasonic irradiation was most significant in the xenograft tumor model compared with the other groups. Nanobubbles carrying AR siRNA could be potentially used as gene vectors in combination with ultrasonic irradiation for the treatment of AIPC.Keywords
This publication has 24 references indexed in Scilit:
- Nanobubbles for enhanced ultrasound imaging of tumorsInternational Journal of Nanomedicine, 2012
- High intensity focused ultrasound in clinical tumor ablationWorld Journal of Clinical Oncology, 2011
- Combined androgen blockade for prostate cancer: Review of efficacy, safety and cost‐effectivenessCancer Science, 2010
- The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agentBiomaterials, 2010
- Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flowJournal of Controlled Release, 2009
- Progression of prostate cancer: Multiple pathways to androgen independenceCancer Letters, 2009
- Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptorThe Journal of Nutritional Biochemistry, 2008
- Microbubbles in ultrasound-triggered drug and gene deliveryAdvanced Drug Delivery Reviews, 2008
- Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumoursThe Journal of Steroid Biochemistry and Molecular Biology, 2006
- Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2005